Abstract Commonly used decision-analytic models for cost-effectiveness analysis simulate time in discrete steps. Use of discrete-time steps can introduce errors when calculating cumulative outcomes such as costs and qualityadjusted life-years. There are a number of myths or misconceptions concerning how to correct these errors and the need to do so. This tutorial shows that, by neglecting to apply within-cycle (sometimes referred to as half-cycle or continuity) correction methods to the results of discretetime models, the analyst may arrive at the wrong recommendation regarding the use of a technology. We show that the standard half-cycle correction method results in the same cumulative outcome as the trapezoidal rule and lifetable method. However, the trapezoidal rule has the added advantage of applying the correction at each cycle, not just the initial and final cycle. We further show that the Simpson's 1/3 rule is more accurate than the trapezoidal rule. We recommend using the Simpson's 1/3 rule in the base-case analysis and, if needed, showing the results with other methods in the sensitivity analysis. We also demonstrate that both the trapezoidal and Simpson's rules can easily be implemented in commonly used software.
Introduction
Most biological and healthcare systems involve events occurring at any time. However, the commonly used decision-analytic models for cost-effectiveness analysis such as the state-transition model (STM) rarely allow time to run continuously. Instead, these models simulate time in discrete steps (known as cycles), and assume transitions of persons from one state to another occur at fixed intervals [1, 2] .
Use of discrete-time steps can introduce errors when calculating cumulative outcomes [3] . The most common approach for correcting the errors in total outcomes that would arise from using a discrete-time STM instead of a continuous-time STM is to add and subtract half of the outcomes in each state from the first cycle and last cycle, respectively. This is known as the standard half-cycle correction (HCC) method either because it adjusts total outcomes by half-cycle outcomes or assumes that transitions occur, on average, halfway through each cycle [3, 4] . Indeed, the ISPOR-SMDM Modeling Good Research Practices Task Force recommends using the standard HCC to costs and effectiveness to correct for continuity of time when using discrete-time STMs [1] . There are also other less known cycle correction methods (e.g., Simpson's rule) that apply correction at each cycle, not only at the first or final cycle [3, 5, 6] .
The published literature includes a number of myths or misconceptions concerning the need for and how to apply cycle correction [7] [8] [9] [10] . The confusion arises mainly from failure to compare the performance of correction methods with the true gold standard-outcomes from a continuoustime STM.
The objective of our study was to provide a tutorial on why within-cycle (sometimes referred to as continuity) correction methods are needed, review different methods for within-cycle correction (WCC), and show how to implement these methods in commonly used modeling packages.
Rationale for Within-Cycle Correction
To demonstrate the need for and evaluate different types of WCC methods, we used a standard three-state (Well, Disease, and Dead) transition model to estimate the clinical benefits and cost effectiveness of a hypothetical intervention to prevent disease progression [11, 12] . Because the purpose of WCC methods is to approximate an underlying continuous-time process with a discrete-time model, we first describe the continuous-time (our gold standard) version of the model, and then show how the discrete-time version of the same model can be constructed.
Model in Continuous Time
Briefly, the model can be described as follows ( Fig. 1 ): in the absence of interventions, the disease progresses at rate p = 4.8 % per year, which results in disease-specific death at rate d = 15 % per year, costs cs = US$8000 per year, and makes the quality of life of a sick person q = 0.95 compared with the quality of life of a well person of 1.0. We assumed that the hypothetical intervention has efficacy h = 50 % and a yearly cost of cw = US$6000. Efficacy is defined according to the following formula: 1 -(incidence rate of disease progression among intervention recipients over years of follow up)/(incidence rate of disease progression among placebo recipients over years of follow up). All-cause mortality is given by the constant m = 5 % per year. We assumed all transition rates are constant over time [13] . We chose a time horizon of T = 30 years, a discount rate of r = 3 % per year, and assumed the threshold for cost effectiveness is k = US$50,000 per quality-adjusted life-year (QALY).
The model can be represented by a system of ordinary differential equations and be solved using standard analytic techniques [14] [15] [16] (Fig. 1) . Using the solution, we determined the number of persons in each health state over time, and derived expressions for life expectancy, discounted QALYs, discounted lifetime costs, and incremental costeffectiveness ratio (ICER) (electronic supplementary material).
Model in Discrete Time
We chose a yearly cycle for the discrete-time model. The appropriate way to discretize time such that the solutions of the discrete-and continuous-time models are identical is to use the matrix exponential of the transition intensity matrix. This will ensure that the correct cycle-specific progression, m all-cause death rate, p transition rate to disease state, q health-related utility of a sick person, QoL quality of life, S disease, W well transition probability matrix is estimated [15] . With the right probability matrix, the model can be represented by a system of difference equations and be solved using standard analytic techniques [12] .
The state-transition probability matrix of the model with and without intervention can be written as in Table 1 . The model is solved using Microsoft Excel (Microsoft Corp., Redmond, WA, USA) to determine the number of persons in each health state at each cycle and calculate relevant outcomes (Fig. 2) . The Excel file can be downloaded from the Journal website (electronic supplementary material).
Rationale for Correction Methods
The major difference between the continuous-time and discrete-time modeling approaches lies in the fact that the solution of the continuous-time model consists of continuous curves as time evolves whereas the solution of the discrete-time model comprises values at cycle ends only. With discrete-time models, the value within a cycle is unknown.
Cumulative outcomes in continuous-time models are obtained using integration techniques, which geometrically is the same as finding the areas under the curves. In contrast, because the health state distribution is available only at cycle ends, discrete-time models employ summation to obtain cumulative outcomes (i.e., area under the curve becomes a staircase). Figure 3 depicts discounted cost of treatment over time using both modeling approaches. Without correction, the area under the curve is approximated by the addition of the solid rectangles. The area is overestimated until Cycle 6 (the rising portion of the curve) and underestimated thereafter (the declining segment of the curve) (Fig. 3) .
As summation is not a good approximation of an integral, there is a need to employ within-cycle (or continuity) correction methods when estimating cumulative outcomes over a period of time (e.g., cumulative treatment cost or life expectancy) using discrete-time models. The outcomes need not be restricted to survival or quality-adjusted survival, but may include any outcome that depends on how long a person stays in a health state and for which one needs to compute a cumulative quantity over a period of time. Examples include intermediate outcomes such as absolute risk of disease over a given number of years as well as final outcomes such as cumulative costs.
Commonly Used Correction Methods
The most commonly used correction approach is known as the standard HCC method. Assuming transitions occur at the beginning of a cycle (i.e., counting state membership at the end of the cycle), this method entails adding to the first cycle and subtracting from the last cycle half of the outcomes in each state [3] . For example, suppose total discounted QALYs without adjustment are 8.632 years, where QALYs in the first cycle and final cycle are 1 and 0.033 years, respectively. The application of HCC requires performing the following calculation: 8.632 ? -0.033/ 2 = 9.116, which provides the adjusted discounted QALYs (Excel file, electronic supplementary material). Fig. 2 The distribution of patients in each health state predicted by both continuous-time (CT) and discrete-time (DT) state-transition models (STM) without the intervention. Heath states: well (green), disease (gray), and dead (red). The solid lines represent the distribution predicted by the CT STM whereas the black dots represent that predicted by the DT STM. It should be noted that the distribution of patients in each health state from the CT model and the DT model at the end of each cycle are identical, confirming the fact that both models track the same survival data (i.e., the data are generated by the same Markov process). Note: h = 0, p = 0.048, m = 0.05, d = 0.15. d transition rate to the death state due to the disease, h probability of intervention halting disease progression, m all-cause death rate, p transition rate to disease state
Others have suggested different approaches that typically apply correction at each cycle, not only at the first or final cycle. These include the life-table method, trapezoidal method, and composite Simpson's rules [6, 7, 9] . If the outcome function and the units of time are defined the same way, the standard HCC method, the trapezoidal rule, and the life-table method will give the same results [16] . For example, the life-table method is typically used to estimate remaining life expectancy for people at different ages (invariable measured in years) from a survivorship table by averaging the number of persons at two consecutive ages and adding together the result across all ages. In this case, the outcome function is given by the survival curve and the unit of time is defined in years. The application of HCC or the trapezoidal rule to the same survival function over years will give the same result as using the lifetable method. The same approach can be applied to other outcome functions such as discounted QALYs.
In this tutorial, our analysis focuses on the well established methods from the field of numerical integration, which are the trapezoidal method, composite Simpson's 1/3 rule, and composite Simpson's 3/8 rule [17] . The trapezoidal method requires taking the average of the outcome at two cycle ends (Fig. 3) . The composite Simpson's 1/3 rule entails multiplying the outcomes by 1/3 in the first cycle, by 4/3 if cycle number is odd, by 2/3 if the cycle number is even, and by 1/3 in the last cycle. Using the composite Simpson's 3/8 rule, one would multiply the outcomes by 3/8 in the first and final cycle, by 9/8 if cycle number is a multiple of 3, and by 6/8 otherwise.
It should be noted that some of the multipliers for Simpson's rules change from cycle to cycle, are not constrained to be less than 1, and do not add up to 1. These patterns follow from the results of the integration of the outcome as a function of time. It is worth mentioning that the Simpson's 1/3 rule assumes that the outcome function can be approximated by a polynomial of degree 2 (i.e., a quadratic equation) whereas the Simpson's 3/8 rule uses a cubic to represent the outcome function. The mathematical derivations of these formulae are provided in Elbasha and Chhatwal [16] .
Implementation of Correction Methods
We illustrate implementation of the three continuity correction methods in a spreadsheet-based tool such as Microsoft Excel (Microsoft Corp., Redmond, WA, USA) Fig. 3 Geometric illustration of the calculation of cumulative discounted cost of disease treatment without continuity correction and using the trapezoidal rule of numerical integration. Without correction, the area under the curve is approximated by the 10 rectangles. The area is overestimated until Cycle 6 (the rising portion of the curve) and underestimated thereafter (the declining segment of the curve). The trapezoidal rule assumes that cost function can be approximated by a straight line connecting the dark points, resulting in a collection of ten trapezoids given by the dashed lines. Because the curve is concave the area under the curve is underestimated with the trapezoidal rule. Note: h = 0, p = 0.048, m = 0.05, d = 0.15, r = 0.03, cs = US$6000. cs cost of disease per year, d transition rate to the death state due to the disease, h probability of intervention halting disease progression, m all-cause death rate, p transition rate to disease state, r discount rate per year and commercial software such as TreeAge (TreeAge Software, Williamstown, MA, USA) (electronic supplementary material). We represent discounted total cost (prevention and treatment cost) at cycle t by C t ¼ cwW t þ cs S t ð Þ ð 1 þ rDÞ Àt ; where W t represents the number of people in the Well state, S t represents the number of people in the Disease state, cw denotes prevention cost, cs denotes disease treatment cost, and rD denotes discount rate per year.
Implementation in Spreadsheet-Based Tool
Compute C t at each cycle (starting from initial cycle where t = 0).
• Trapezoidal rule starting at first cycle (where t = 1), compute the average at the beginning and end of a cycle, fx = (C t-1 ? C t )/2, at each cycle and add up to obtain total cost. 
Implementation in TreeAge
• Trapezoidal rule using _stage variable, set Init Rwd = C 0 /2, Final Rwd = C T /2; and Incr Rwd = discount(cost; rD; _stage), where 'cost' is the cost associated with a given state, T is the terminal stage, and rD is the discount rate.
• Simpson's 1/3 rule using function discount, modulo, and _stage, set Init Rwd = C 0 /3; Final Rwd = discount(cost; rD; T)/3; and Incr Rwd = if(modulo(_stage;2) = 0; 2; 4)*discount(cost; rD; _stage)/3. It should be noted that the above approach is based on a model with an annual cycle length. If a different cycle length is used, one would need to multiply total outcomes by the length of the cycle in years in order to compute outcomes on an annual basis. Table 2 shows the results of the cost effectiveness of an intervention with and without continuity corrections. The approximation errors without applying any continuity correction are significant. The absolute difference between QALYs without correction and QALYs using the exact value of the integral is as high as 0.476 QALYs. The absolute error in total discounted cost with the intervention is -US$2785. As a result, the ICER without continuity correction is underestimated by 3446/QALY.
Comparison of Correction Methods
This example illustrates the situation where a wrong decision can be made if no continuity correction is applied ( Table 2) . The ICERs using all the three correction methods are consistent with the gold standard ICER of US$51,374/QALY, indicating that the intervention is not cost effective at a threshold of US$50,000/QALY. However, without continuity correction, the ICER is US$47,929/QALY, suggesting cost effectiveness of the intervention, clearly a wrong recommendation to follow.
The results also suggest that the standard HCC method and trapezoidal rule are not as accurate as the Simpson's 1/3 and 3/8 rules. Compared with the gold standard, the latter methods are more accurate, especially when estimating discounted QALYs.
Elbasha and Chhatwal [16] present an example where none of the three continuity correction methods are accurate enough when compared with the gold standard. The example shows that the intervention is cost effective using the gold standard and not cost effective when the standard HCC method and the Simpson's 1/3 and 3/8 rules are applied.
Outcomes Requiring Correction
Any cumulative outcome that is calculated using a discretetime decision-analytic model may require adjustment using a WCC method. However, not all outcomes should be subjected to WCC. Whether to apply WCC or not is, therefore, dependent on the nature of the outcome and the timing of its realization during a cycle. It is important that analysts are careful with regards to assumptions they make explicitly or implicitly when applying WCC. This section provides examples of types of cumulative outcomes that require adjustment and others where no adjustment should be performed (Table 3) . We focus only on outcomes calculated using state-transition models.
The original report of the ISPOR Task Force on Good Research Practices-Modeling Studies [18] suggested applying cycle correction to QALYs when the differences in quality-adjusted survival between alternatives are less than one cycle length, but did not mention adjustment of costs or other outcomes. The recent report of the ISPOR-SMDM Modeling Good Research Practices Task Force recommended applying the correction to both costs and effectiveness, but did not provide details on the types of costs and effectiveness for which WCC should or should not be applied [1] .
There seems to be an agreement on applying WCC when effectiveness is measured by unadjusted or quality-adjusted life-years. What is not clear is whether the adjustment is needed or not when intermediate outcomes are used to measure health outcomes. One of the commonly used metrics in cost-effectiveness analysis with a long time horizon is cases of disease resulting from using a given intervention. Because the risk of disease over a period is determined by a cumulative hazard, which is an integral of the hazard rate and persons at risk (whose number changes within a cycle), cumulative cases of disease require WCC. The same logic applies to cumulative adverse events calculated using a state-transition model.
Most costs in state-transition models accrue as a result of being in a given health state during a cycle, regardless of how long a person has been in this health state. These are sometimes referred to as prevalence-based costs and are subject to WCC. However, there are some state-transition models that also include incidence-based costs where the model does not describe the course and duration of a condition. Instead, the lifetime costs of such a condition are obtained outside the model. These costs need to be appropriately discounted and are also subject to WCC. An example of an incidence-based approach to cost estimation is lifetime cost of a diagnosed cancer case. A model that does not include all stages of cancer may rely on outside estimates of costs and combine these with number of patients diagnosed with cancer from the model to estimate total discounted costs of cancer using a given intervention. In this, WCC should be applied only once and only after computing discounted costs of cancer cases. One-time event-driven costs that accrue as a person transitions from one health state to another (sometimes referred to as transition costs) should be appropriately adjusted using a WCC method and a correct discounting factor depending on their time of occurrence. For example, in a model with end-stage liver disease, the cumulative cost of liver transplantation should be discounted at the time of occurrence and adjusted using a WCC method.
Intervention costs may or may not require WCC depending on the time, duration, and person receiving an intervention. Costs of an intervention that is completed before a person enters the model are not subject to discounting or WCC. An example of this is upfront costs of adminstering a vaccine before the simulation begins. Costs of interventions that are implemeted after the model starts, whether they are implemented at a single point of time or continuously over time, are subject to WCC. For example, WCC should be applied when estimating costs of a drug that is taken over a period of time where some patients may discontinue treatment.
It should be mentioned that WCC can be applied to individual components of a cumulative outcome before adding them together or WCC can be applied at the end after all unadjusted individual components are added up. For example, to obtain total discounted QALYs one can either apply WCC to discounted quality-adjusted survival time in the Well state and Disease state separately and tally the result, or add together the discounted quality-adjusted survival time in both health states and then apply WCC. Either way, the resulting total QALYs should be the same.
Myths and Misconceptions of Continuity Correction Methods
There are a number of misconceptions that are common in the literature concerning the need for and application of the standard HCC specifically or continuity correction methods in general [16] . We discuss a few of these myths and facts.
1. Myth WCC is needed to correctly estimate state membership in discrete-time STM. Fact if the transition probability matrix is constructed correctly, the state membership in a discrete-time STM will be the same as that in a continuous-time STM (Fig. 2) . Although the discrete-time STM calculates state membership only at discrete time points, these calculations require no assumptions about when the transitions occur within a cycle. Therefore, WCC methods are not needed when calculating state memberships, but are needed to calculate cumulative outcomes. 2. Myth if one applies WCC to state membership, all cumulative outcomes are calculated correctly. Fact this is true only for special outcomes (e.g., undiscounted survival) and leads to erroneous results if applied to state memberships to calculate most other outcomes (e.g., discounted quality-adjusted survival). This is because some cumulative outcomes do not depend only on state membership, but also on other time-varying factors. For example, discounted qualityadjusted survival has two multiplicative components that vary with time: state membership and discounting factor. 3. Myth HCC is not compatible with discounting. This claim was made frequently in the recent debate on HCC [7] [8] [9] [10] . For example, Barendregt [9] erroneously arrived at different results using the life-table method compared with the HCC. Fact All cycle correction methods, including HCC, are compatible with discounting. The correct approach is to apply correction methods to the discounted outcomes (i.e., apply discounting before cycle correction). 4. Myth if one assumes transitions occur at the beginning of a cycle, not applying HCC will underestimate cumulative outcomes. Fact this is true only if the outcome function (e.g., survival function) is monotonically decreasing with respect to time. In fact, the opposite is true if the function in question is monotonically increasing: not applying HCC overestimates cumulative outcomes when transitions occur at the beginning of a cycle. This is illustrated in Fig. 3 where disease treatment cost increases over time until Year 6, after which the cost goes down. Clearly, the area of the first six rectangles is more than the actual shaded area under the curve during the first 6 years. Similarly, the shaded area under the curve between years 6 and 10 is more than the area obtained by adding up the area of the last four rectangles. Whether applying HCC (trapezoidal rule) will underestimate or overestimate cumulative outcomes compared with the gold standard depends on the curvature of the function. If the function is concave (convex), HCC underestimates (overestimates) cumulative outcomes. This claim can be proved by observing that the trapezoidal rule approximates a function using a line segment which always falls below a concave function or above a convex function (Fig. 3) Fact regardless of how good the method is, there is no guarantee that the approximation error will vanish as long as time is assumed to be discrete. 8. Myth if the cycle length is short, there is no need to apply WCC. Fact no matter how small the cycle length is, a discrete-time model will always result in errors in the estimation of cumulative outcomes. This is because the discrete-time model can only use discrete data to estimate the area of a continuous curve. However, it is true that the approximation error becomes smaller as the cycle length gets shorter provided that a correct method of converting transition probabilities to a shorter cycle length is used [19] . Further, the approach for WCC should be the same regardless of the length of the cycle (i.e., where the model is defined using a semiannual, annual or biannual cycle).
Discussion
Calculation of cumulative outcomes using discrete-time models is subject to errors. We reviewed commonly used methods to reduce these errors, and clarified several misconceptions regarding their application. The standard application of HCC requires adjusting outcomes only in the initial and final cycle in order to estimate cumulative outcomes. We show that with careful definition of the outcome functions, standard HCC resulted in the same cumulative outcome as the trapezoidal rule [16] . However, the values of outcomes at intermediate cycles remain uncorrected and may differ significantly from those using the trapezoidal rule or the gold standard (Fig. 3) . Therefore, it seems appropriate to apply the trapezoidal rule at each cycle. We further found that the standard HCC and trapezoidal rule have less accuracy than the Simpson's 1/3 or 3/8 rule when compared with the gold standard. In contrast to an earlier study that recommended the trapezoidal rule over the Simpson's rule [8] , we recommend the Simpson's 1/3 rule because of its higher accuracy in comparison with trapezoidal rule. We also recommend using one method (preferably Simpson's 1/3 rule) for the base-case analysis and, if needed, showing the results with other methods in the sensitivity analysis. We showed that it is straightforward to implement all three methods within commonly used software such as Microsoft Excel (Microsoft Corp., Redmond, WA, USA) and TreeAge (TreeAge Software, Williamstown, MA, USA).
Discrete-time STMs have become the most commonly used methods for economic and decision analysis in healthcare. We recommend that cycle correction should always be applied in a correct way. Even if it is performed correctly, at best, a correction method is just an approximation, not a gold standard. Other modeling options such as continuous-time state-transition models or discrete-event simulations do not require the use of cycle correction, and could sometimes be used for more accurate results [14, 20] . Another recently emerging modeling technique, agentbased modeling [21] , may or may not require cycle correction depending on the way time is simulated.
It is not entirely obvious why the standard method is called half-cycle correction. This may be because it adjusts total outcomes by half-cycle outcomes. It is also frequently stated that the standard HCC method is based on the assumption that transitions occur halfway through the cycle [1] . However, this is not an accurate statement because it implies that the outcome function can be evaluated at the midpoint of the cycle which typically cannot be implemented in practice. We advocate the renaming of halfcycle correction to either within-cycle correction or continuity correction. This is because some of the methods do not use half-cycle outcomes or do not assume that transitions occur, on average, halfway through each cycle. These methods only make assumptions about the curvature of the outcome function throughout the cycle, and not just its value at halfway through a cycle.
Although we used a simple example for illustration purposes, our approach is very general and can be applied to any model structure. This includes any discrete-time model with several heath states, a Markov process (where history matters) with time-varying inputs, or a simple Markov chain with constant probabilities. Regardless of the model structure, the algorithms for WCC methods provided in this paper should be applied in exactly the same way.
To highlight the importance of applying WCC methods and the effects of the selected type of WCC method on ICER and its implication for adopting or rejecting an intervention, we picked scenarios where the ICER is close to the threshold for cost effectiveness. This may seem a rare situation at first glance. However, the example provided by Jena and Philipson suggests that this may be more common in the context of CEA used to guide reimbursement decisions [22, 23] . According to Jena and Philipson, the costs incorporated into health technology assessments (HTA) are directly related to the prices charged to payers by innovators or manufacturers. When an HTA agency only recommends technologies that are cheaper than a fixed cost-effectiveness threshold, manufacturers may find it optimal to set prices such that their technologies have ICERs at or below such thresholds. Jena and Philipson refer to the phenomenon of reimbursement guided by the cost-effectiveness criteria where ICERs reflect prices set by manufacturers as endogenous cost effectiveness.
We focused in our numerical illustrative examples on the effect of WCC on ICER and its implication for adopting or rejecting an intervention. However, WCC methods are needed to accurately estimate any cumulative outcome. Recent recommendations stress the importance of a model's ability to accurately predict outcomes [24] . Because a model's validity is frequently tested using intermediate outcomes over a short period of time, whether to apply WCC or which method to choose for calculating those outcomes can affect validation results and, ultimately, confidence in the model's results.
In conclusion, we show that results of discrete-time models may lead to the wrong recommendation regarding the use of a technology if an accurate continuity correction is not appropriately applied. Although the standard halfcycle correction method results in the same cumulative outcome as the trapezoidal rule and life-table method, the trapezoidal rule has the added advantage of applying the correction at each cycle, not just the initial and final cycles. However, the Simpson's 1/3 rule is more accurate than the trapezoidal rule. We recommend using the Simpson's 1/3 rule in the base-case analysis and, if needed, showing the results with other methods in the sensitivity analysis. We also demonstrate that both the trapezoidal and Simpson's rules can easily be implemented in commonly used software.
